| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS–FLI1 fusion transcript
|
Grohar, Patrick J.
|
|
2017
|
80 |
3 |
p. 645-652
|
article
|
| 2 |
A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
|
Fountzilas, Christos
|
|
2017
|
80 |
3 |
p. 497-505
|
article
|
| 3 |
A phase I study to investigate the metabolism, excretion, and pharmacokinetics of [14C]fruquintinib, a novel oral selective VEGFR inhibitor, in healthy Chinese male volunteers
|
Zhou, Sufeng
|
|
2017
|
80 |
3 |
p. 563-573
|
article
|
| 4 |
A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients
|
Imai, Hisao
|
|
2017
|
80 |
3 |
p. 615-622
|
article
|
| 5 |
A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics
|
Badowski, Melissa E.
|
|
2017
|
80 |
3 |
p. 441-449
|
article
|
| 6 |
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer
|
Mbatchi, Litaty C.
|
|
2017
|
80 |
3 |
p. 653-659
|
article
|
| 7 |
Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study
|
Shiroyama, Takayuki
|
|
2017
|
80 |
3 |
p. 461-467
|
article
|
| 8 |
Case series on the association between blood levels and side effects of afatinib maleate
|
Sato, Junya
|
|
2017
|
80 |
3 |
p. 545-553
|
article
|
| 9 |
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients
|
Makihara, Katsuya
|
|
|
80 |
3 |
p. 527-533
|
article
|
| 10 |
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients
|
Makihara, Katsuya
|
|
2017
|
80 |
3 |
p. 527-533
|
article
|
| 11 |
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy
|
Bilen, Mehmet Asim
|
|
2017
|
80 |
3 |
p. 583-589
|
article
|
| 12 |
Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors
|
Kim, Hee Kyung
|
|
2017
|
80 |
3 |
p. 591-598
|
article
|
| 13 |
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma
|
Gordeyev, Sergey S.
|
|
|
80 |
3 |
p. 623-629
|
article
|
| 14 |
Concurrent paclitaxel, capecitabine, mitomycin C and pelvic radiation therapy for patients with squamous cell anal carcinoma
|
Gordeyev, Sergey S.
|
|
2017
|
80 |
3 |
p. 623-629
|
article
|
| 15 |
Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcoma
|
Miladi, Imen
|
|
2017
|
80 |
3 |
p. 517-526
|
article
|
| 16 |
Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study
|
Iizumi, Sakura
|
|
2017
|
80 |
3 |
p. 575-582
|
article
|
| 17 |
Exposure–response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial
|
Cohn, Allen Lee
|
|
2017
|
80 |
3 |
p. 599-608
|
article
|
| 18 |
Impact of an alternative steroid on the relative bioavailability and bioequivalence of a novel versus the originator formulation of abiraterone acetate
|
Hussaini, Azra
|
|
2017
|
80 |
3 |
p. 479-486
|
article
|
| 19 |
Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers
|
Gerisch, Michael
|
|
2017
|
80 |
3 |
p. 535-544
|
article
|
| 20 |
Phase I study of veliparib in combination with gemcitabine
|
Stoller, Ronald
|
|
2017
|
80 |
3 |
p. 631-643
|
article
|
| 21 |
Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers
|
Yoshikawa, Tomoyuki
|
|
2017
|
80 |
3 |
p. 555-561
|
article
|
| 22 |
Risk of venous and arterial thromboembolic events associated with VEGFR-TKIs: a meta-analysis
|
Liu, Bo
|
|
2017
|
80 |
3 |
p. 487-495
|
article
|
| 23 |
Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer
|
Panis, C.
|
|
2017
|
80 |
3 |
p. 469-478
|
article
|
| 24 |
sIL-24 peptide, a human interleukin-24 isoform, induces mitochondrial-mediated apoptosis in human cancer cells
|
Valiyari, Samira
|
|
2017
|
80 |
3 |
p. 451-459
|
article
|
| 25 |
Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China
|
Wang, Yuhong
|
|
2017
|
80 |
3 |
p. 507-516
|
article
|
| 26 |
Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer
|
Kenmotsu, Hirotsugu
|
|
2017
|
80 |
3 |
p. 609-614
|
article
|
Journal description